Elegen

Elegen is a synthetic biology company founded in 2017 and headquartered in Menlo Park, California that manufactures high-accuracy synthetic DNA through its proprietary cell-free ENFINIA platform. Rather than relying on traditional cell-based cloning, ENFINIA combines microfluidics, artificial intelligence, and robotics to produce long, clonal-quality, high-complexity DNA at speed and low cost. The ENFINIA product line includes Linear DNA up to 7 kb delivered in 6-8 business days, Plasmid DNA up to 15 kb, and IVT Ready DNA with encoded poly(A) tails for mRNA workflows, each NGS-verified to 99.999% per-base accuracy. Elegen serves researchers and therapeutics developers across mRNA vaccines, cell and gene therapy, CRISPR genome editing, and protein expression. Customers submit and order sequences through the online ENFINIA ordering portal; Elegen does not currently publish a public developer API. The company is backed by a16z Bio + Health, KdT Ventures, 8VC, Digitalis Ventures, Agilent, and others, and raised a $35M Series B in 2024.

Elegen is profiled on the APIs.io network. Tagged areas include Company, Synthetic Biology, DNA Synthesis, Biotechnology, and Genomics.

Elegen’s developer surface includes developer portal, documentation, support, engineering blog, pricing, signup flow, and 8 more developer resources.

🌐 Visit website 📡 Source on GitHub

20.4/100 emerging ▬ flat Agent 0/100 human only saas Full breakdown ↓
scored 2026-09-08 · rubric v0.20.0

0 APIs

Company Synthetic Biology DNA Synthesis Biotechnology Genomics Gene Synthesis Life Sciences mRNA Cell and Gene TherapySynthetic DNA

Kin Score

Kin Score How this is scored →
scored 2026-09-08 · rubric v0.20.0

Composite quality — 20.4/100 · emerging

Contract Quality 0.0 / 21

Developer Ergonomics 4.5 / 17

Access Clarity 7.6 / 17

Operational Transparency 0.6 / 11

Contract Governance 0.0 / 10

Discoverability 4.9 / 9

Regulatory Posture 2.6 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Delegated User Identity 0 / 6

Protected Resource Metadata 0 / 5

Registration Without a Human 0 / 6

Agentic Commerce Well-Known Document 0 / 5

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero: never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and several others — scorable at all.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/elegen: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Elegen Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Get Started 2

Portal, sign-up, and the first successful call

Portal

Portal

SignUp

SignUp

Documentation 1

Reference material describing how the API behaves

Documentation

Documentation

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt

LLMsTxt

Build 1

SDKs, sample code, and the tooling you integrate with

GitHubOrganization

GitHubOrganization

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 3

Pricing, plans, and the legal terms of use

Pricing

Pricing

PrivacyPolicy

PrivacyPolicy

TermsOfService

TermsOfService

Company 4

The organization behind the API

Website

Website

Blog

Blog

LinkedIn

Twitter

Twitter

Source (apis.yml)

aid: elegen
name: Elegen
description: Elegen is a synthetic biology company founded in 2017 and headquartered in Menlo Park, California that manufactures
  high-accuracy synthetic DNA through its proprietary cell-free ENFINIA platform. Rather than relying on traditional cell-based
  cloning, ENFINIA combines microfluidics, artificial intelligence, and robotics to produce long, clonal-quality, high-complexity
  DNA at speed and low cost. The ENFINIA product line includes Linear DNA up to 7 kb delivered in 6-8 business days, Plasmid
  DNA up to 15 kb, and IVT Ready DNA with encoded poly(A) tails for mRNA workflows, each NGS-verified to 99.999% per-base
  accuracy. Elegen serves researchers and therapeutics developers across mRNA vaccines, cell and gene therapy, CRISPR genome
  editing, and protein expression. Customers submit and order sequences through the online ENFINIA ordering portal; Elegen
  does not currently publish a public developer API. The company is backed by a16z Bio + Health, KdT Ventures, 8VC, Digitalis
  Ventures, Agilent, and others, and raised a $35M Series B in 2024.
url: https://raw.githubusercontent.com/api-evangelist/elegen/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- a16z
x-tier: stub
x-tier-reason: portfolio-lead
deliveryModel:
  model: saas
  open_source: false
  commercial: true
  callable_host: false
  label: Hosted service · you call their endpoint
  confidence: medium
  source:
  - pricing
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://elegenbio.com/wp-content/uploads/2025/08/elegen-mark-200x200-1.png
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Synthetic Biology
- DNA Synthesis
- Biotechnology
- Genomics
- Gene Synthesis
- Life Sciences
- mRNA
- Cell and Gene Therapy
- Synthetic DNA
apis: []
common:
- type: DomainSecurity
  url: security/elegen-domain-security.yml
- type: Website
  url: https://elegenbio.com/
- type: Portal
  name: ENFINIA Ordering Portal
  url: https://ecommerce.elegen.com/
- type: Documentation
  name: Elegen Support & Product Documentation
  url: https://support.elegenbio.com/
- type: Support
  name: Elegen Help Center
  url: https://support.elegenbio.com/
- type: Blog
  name: Elegen News
  url: https://elegenbio.com/news/
- type: GitHubOrganization
  name: ElegenBio on GitHub
  url: https://github.com/ElegenBio
- type: Pricing
  name: ENFINIA GEN II Pricing
  url: https://elegenbio.com/technology/gen-ii-pricing-announcement/
- type: SignUp
  name: ENFINIA Portal Sign Up / Login
  url: https://ecommerce.elegen.com/auth/login
- type: PrivacyPolicy
  url: https://elegenbio.com/privacy-policy/
- type: TermsOfService
  name: Terms and Conditions of Sale
  url: https://support.elegenbio.com/en/kb/terms-and-conditions-of-sale
- type: LinkedIn
  url: https://www.linkedin.com/company/elegenbio/
- type: Twitter
  url: https://x.com/ElegenBio
- type: LLMsTxt
  name: Elegen llms.txt
  url: llms/elegen-llms.txt
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this

find_providersBrowse and filter every provider in the catalog.
get_provider_artifactsEvery artifact this provider publishes, grouped by type.
get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
get_provider_ratingPRO — composite, band, trend and facet scores.
apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
resolveTurn a domain, URL or GitHub org into the provider it belongs to.
find_cohortsEvery scored population of providers in the catalog.

All 92 tools →

Call it yourself

curl for this page

This provider

curl "https://apis.io/api/v1/providers/elegen"

All providers

curl "https://apis.io/api/v1/providers?limit=25"

Every operation they expose

curl "https://apis.io/api/v1/providers/elegen/operations?limit=25"

How their score was established

curl "https://apis.io/api/v1/providers/elegen/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no form to fill in. Signing in shares your email address with us — we store it to create your key and to recognise you if you sign in with another provider. See our Privacy Policy and Terms.

GitHub Google LinkedIn

A second provider on the same verified email joins the account you already have.